D-0060-2023 Class II Terminated

Recalled by ImprimisRx NJ — Ledgewood, NJ

Recall Details

Product Type
Drugs
Report Date
November 23, 2022
Initiation Date
November 9, 2022
Termination Date
August 23, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
960 bottles

Product Description

Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.

Reason for Recall

Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

Distribution Pattern

Nationwide in the USA

Code Information

Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023